Biologics Market Augmented to Reach USD 596.65 Billion with Competitive Dynamics & Global Outlook by 2029

Data Bridge Market Research Published Latest Global Biologics Market Study by in-depth analysis about current scenario, the Market size, demand, growth pattern, trends, and forecast.

Biologics market analysis report is produced in such a way that it works toward making the reports easier to read, and easier for managers to absorb the information they need to make decisions. The market information of this report is made more accessible to the clients. This industry analysis report contains actionable research and is also educational and entertaining. The varied and in-depth market report helps businesses get a data-focused perspective on the topics shaping industries and geographic areas. The comprehensive Biologics market document gathers and analyzes data about customers, competitors, distributors, and other factors and forces in the marketplace very efficiently.

Data Bridge Market Research analyses that the biologics market was valued at USD 264 billion in 2021 and is expected to reach USD 596.65 billion by 2029, registering a CAGR of 9.25% during the forecast period of 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Get Sample PDF Brochure @

Key Market Players mentioned in this report:

  • Pfizer Inc. (US)
  • GlaxoSmithKline plc (UK)
  • Novartis AG (Switzerland)
  • Mylan N.V. (US)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Sanofi (France)
  • Boehringer Ingelheim International GmbH. (Germany)
  • AstraZeneca (UK)
  • Johnson & Johnson Private Limited (US)
  • Merck & Co., Inc. (US)
  • F. Hoffmann-La Roche Ltd. (Switzerland)

Key Market Analysis and Insights:

Biologics have acquired a lot of momentum in recent years since they are used to treat a variety of diseases and ailments, such as Crohn's disease, ulcerative colitis, rheumatoid arthritis, and other autoimmune diseases. The product's widespread use is expected to drive growth in the global biologics market in the coming years. Biologics are at the cutting edge of research, supporting the most recent advances. Such breakthroughs are expected to result in revolutionary treatments that give patients new treatment options. New developments and unique therapies are being developed for the production of new biologics, indicating that the global biologics market is anticipated to have a positive future outlook.

Biologics, commonly referred to as biological medications, are disease-modifying antirheumatic drugs (DMARDs) that are manufactured from live creatures or contain living organism components. Vaccines, blood, blood components, tissues, cells, allergies, genes, and recombinant proteins are among the items derived from humans, insects, microbes, animals, plants, and birds. These products regulate the development of essential proteins, alter human hormones and cells, and produce compounds that either activate or suppress the immune system. They also alter the way natural biologic intracellular and cellular activities function.

Browse Full Report Along With Facts and Figures @

Global Biologics Market Scope

The biologics market is segmented on the basis of type, drug class, therapeutic application, source, manufacturing, drug type, mode of purchase, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.


  • Tumor Necrosis Factor (TNF) Inhibitor
  • T-cell Inhibitor
  • Selective Co-stimulation Modulators
  • Interleukin-6 (IL-6) or Interleukin-17 Blocker
  • Interleukin-1 (IL-1) Blocker
  • B-cell Inhibitor

Therapeutic Application

  • Oncology
  • Autoimmune/Immunologic Diseases
  • Metabolic Disorders
  • Ophthalmic Diseases
  • Respiratory Disorders
  • Inflammatory Bowel Diseases (IBDs)
  • Neurological Disorders
  • Cardiovascular Diseases (CVDs)
  • Musculoskeletal Disorders (MSDs)
  • Infectious Diseases
  • Others


  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Biologics Market, By Region:

The Global Biologics Market is analysed and market size insights and trends are provided by country, drug type, drug class, therapeutic application, source, manufacturing, drug type, mode of purchase, dosage form, route of administration, end-users and distribution channel as referenced above.

The countries covered in the biologics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the biologics market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players and rising healthcare expenditure will further propel the market's growth rate in this region. Additionally, increase in strategic collaborations for the development of biologics treatment for acute as well as chronic diseases will further propel the market's growth rate in this region.

Inquire Before Buying This Research Report@

Biologics Market Dynamics:


Rise in the prevalence of chronic diseases

The surging prevalence of chronic diseases is a major factor driving the biologics market's growth rate during the forecast period of 2022-2029. As per World Health Organization (WHO), chronic diseases kill more than 41 million people worldwide each year. The most common chronic disease, cardiovascular disease, kills 17.9 million people per year, followed by cancer, diabetes and respiratory disorders. These four groups are responsible for 80% of all chronic disease mortality. Chronic diseases have prompted the development of sophisticated diagnostics and therapeutics. Biologics are medicines that have been genetically modified to target a portion of the immune system that causes inflammation.

Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of biologics market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the biologics market. Additionally, sedentary lifestyle of people and surging geriatric population will result in the expansion of biologics market. Along with this, favourable reimbursement policies will enhance the market's growth rate.

 Table of Contents: Global Biologics Market

1 Introduction
2 Market Segmentation
3 Executive Summary
4 Premium Insight
5 Market Overview
6 Covid-19 Impact on Biologics in Healthcare Industry
7 Global Biologics Market, by Product Type
8 Global Biologics Market, by Modality
9 Global Biologics Market, by Type
10 Global Biologics Market, by Mode
11 Global Biologics Market, by End User
12 Global Biologics Market, by Geography
13 Global Biologics Market, Company Landscape
14 Swot Analysis
15 Company Profiles
16 Questionnaire
17 Related Reports

Check Complete Table of Contents @

Top Trending Reports of Healthcare Industry:

Protein Purification and Isolation Market – Global Industry Trends and Forecast to 2029 |

Cold Plasma Market – Global Industry Trends and Forecast to 2029 |

Oxytocic Pharmaceutical Market – Global Industry Trends and Forecast to 2027 |

Robot Assisted Percutaneous Coronary Intervention (PCI) Market – Global Industry Trends and Forecast to 2028 |

Veterinary Pain Management Market Trends, demand, Size, & Forecast To 2029.

Medical Camera Market – Global Industry Trends and Forecast to 2028 |

Bipolar Disorder Treatment Market – Global Industry Trends and Forecast to 2029 l

Surgical Visualization Products Market – Global Industry Trends and Forecast to 2028 |

Point-of-Care Testing (POCT) Market – Industry Trends and Forecast to 2028 l

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475


Back to news